Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioNTech SE ADR buy MoneyMoney

BioNTech SE ADR
Start price
€210.00
14.11.21 / 0%
Target price
€185.00
14.11.22
Performance (%)
-25.98%
End price
€155.45
15.11.22
Summary
This prediction ended on 15.11.22 with a price of €155.45. The prediction for BioNTech SE ADR disappointed with a performance of -25.98%. MoneyMoney has a follow-up prediction for BioNTech SE ADR where he still thinks BioNTech SE ADR is a Buy. This prediction was marked as speculative and is excluded from MoneyMoney's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
BioNTech SE ADR 7.896% 7.896% 243.124%
iShares Core DAX® 0.476% -0.039% 13.342%
iShares Nasdaq 100 1.290% 0.504% 40.099%
iShares Nikkei 225® 1.300% -2.135% 19.861%
iShares S&P 500 0.829% 0.193% 29.756%

According to MoneyMoney what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Differentiated customer and product portfolio
Valuable balance sheet
High Investments for future growth
Future proof or reliable business model
Capable Management
Innovative
Growths faster than the competition
Stable Large shareholder and/or long term investor
Revenue growth > 30% per year expected
Well known brand
Top 10 in its market
Could be worthwhile Investment >10% per year
Good culture
Strong uniques
positive Cash Flow expected
Sustainability is important
Good rating
Cons
Higher risks for its business
Significant cyclical dependencies
Low dividend yield expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital

Comments by MoneyMoney for this prediction

In the thread Biontech SE diskutieren
Prediction Buy
Perf. (%) -25.98%
Target price 250.000
Change
Ends at 14.11.22

Buy mit Kursziel 250,0

MoneyMoney 
0
Report Share
14.11.21
Prediction Buy
Perf. (%) -25.98%
Target price 360.000
Change
Ends at 14.11.22

Kursziel geändert auf 360,0

MoneyMoney 
0
Report Share
27.11.21
Prediction Buy
Perf. (%) -25.98%
Target price 270.000
Change
Ends at 14.11.22

Kursziel geändert auf 270,0

MoneyMoney 
0
Report Share
12.12.21
Prediction Buy
Perf. (%) -25.98%
Target price 260.000
Change
Ends at 14.11.22

Kursziel geändert auf 260,0

MoneyMoney 
0
Report Share
25.12.21
Prediction Buy
Perf. (%) -25.98%
Target price 150.000
Change
Ends at 14.11.22

Kursziel geändert auf 150,0

MoneyMoney 
0
Report Share
22.02.22
Prediction Buy
Perf. (%) -25.98%
Target price 190.000
Change
Ends at 14.11.22

Kursziel geändert auf 190,0

MoneyMoney 
0
Report Share
19.03.22
Prediction Buy
Perf. (%) -25.98%
Target price 200.000
Change
Ends at 14.11.22

Kursziel geändert auf 200,0

MoneyMoney 
0
Report Share
19.03.22
Prediction Buy
Perf. (%) -25.98%
Target price 190.000
Change
Ends at 14.11.22

Kursziel geändert auf 190,0

MoneyMoney 
0
Report Share
17.04.22
Prediction Buy
Perf. (%) -25.98%
Target price 180.000
Change
Ends at 14.11.22

Kursziel geändert auf 180,0

MoneyMoney 
0
Report Share
15.05.22
Prediction Buy
Perf. (%) -25.98%
Target price 190.000
Change
Ends at 14.11.22

Kursziel geändert auf 190,0

MoneyMoney 
0
Report Share
28.05.22
Prediction Buy
Perf. (%) -25.98%
Target price 175.000
Change
Ends at 14.11.22

Kursziel geändert auf 175,0

MoneyMoney 
0
Report Share
12.06.22
Prediction Buy
Perf. (%) -25.98%
Target price 200.000
Change
Ends at 14.11.22

Kursziel geändert auf 200,0

MoneyMoney 
0
Report Share
10.07.22
Prediction Buy
Perf. (%) -25.98%
Target price 180.000
Change
Ends at 14.11.22

Kursziel geändert auf 180,0

MoneyMoney 
0
Report Share
24.07.22
Prediction Buy
Perf. (%) -25.98%
Target price 210.000
Change
Ends at 14.11.22

Kursziel geändert auf 210,0

MoneyMoney 
0
Report Share
06.08.22
Prediction Buy
Perf. (%) -25.98%
Target price 170.000
Change
Ends at 14.11.22

Kursziel geändert auf 170,0

MoneyMoney 
0
Report Share
17.09.22
Prediction Buy
Perf. (%) -25.98%
Target price 165.000
Change
Ends at 14.11.22

Kursziel geändert auf 165,0

MoneyMoney 
0
Report Share
29.10.22
Prediction Buy
Perf. (%) -25.98%
Target price 180.000
Change
Ends at 14.11.22

Kursziel geändert auf 180,0

MoneyMoney 
0
Report Share
13.11.22
Prediction Buy
Perf. (%) -25.98%
Target price 185.000
Change
Ends at 14.11.22

Kursziel geändert auf 185,0

MoneyMoney 
0
Report Share
14.11.22
In the thread Trading Biontech SE
Prediction Buy
Perf. (%) -25.98%
Target price 185.000
Change
Ends at 14.11.22

Die von MoneyMoney gewählte maximale Laufzeit wurde überschritten

MoneyMoney 
0
Report Share
15.11.22

Current prediction by MoneyMoney for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€81.35
18.04.24
€100.00
18.04.25
6.39%
10:27

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
MoneyMoney 
18.04.24 0%

Stopped prediction by MoneyMoney for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€160.55
11.12.22
€120.00
11.12.23
-42.05%
12.12.23

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
MoneyMoney 
11.12.22 0%
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€67.74
13.07.20
€250.00
04.11.21
254.74%
05.11.21

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
MoneyMoney 
13.07.20 0%